December 02, 2024

2024 Vitamin D Guidelines: A Critical Review

"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."

Conexiant

November 01, 2023

What's New

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

May 01, 2023

Virtual Reality in Retina

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician

June 01, 2023

LEADING OFF How AI Could Shape Eye Care

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

May 01, 2023

CODING Q&A Minor Surgery but Not Minor Documentation

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician

September 01, 2023

BUSINESS Legal

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

July 01, 2023

GA THERAPIES ON THE WAY

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

July 01, 2023

BUSINESS Coding Strategy

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

February 06, 2023

Unlocking the Promise of Nanomaterials

It used to be that if you received a diagnosis of glaucoma, chances were good that you would eventually lose vision to some degree. That began to change with the development of drugs that lower intraocular pressure, elevated levels of which can drive glaucoma.

Johns Hopkins Medicine